Zobrazeno 1 - 10
of 29
pro vyhledávání: '"José Andres Yunes"'
Autor:
Pablo Ferreira das Chagas, Graziella Ribeiro de Sousa, Márcio Hideki Kodama, Carlos Alberto Oliveira de Biagi Junior, José Andres Yunes, Silvia Regina Brandalise, George Adrian Calin, Luiz Gonzaga Tone, Carlos Alberto Scrideli, Jaqueline Carvalho de Oliveira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 1, Pp 28-34 (2021)
Aberrant expression of long non-coding RNAs (lncRNAs) has been detected in several types of cancer, including acute lymphoblastic leukemia (ALL), but lncRNA mapped on transcribed ultraconserved regions (T-UCRs) are little explored. The T-UCRs uc.112,
Externí odkaz:
https://doaj.org/article/ccfecd83e4494bf6ae3e02e9a3a4b34d
Autor:
Taciani de Almeida Magalhães, Gustavo Alencastro Veiga Cruzeiro, Graziella Ribeiro de Sousa, Bernhard Englinger, Luis Fernando Peinado Nagano, Mathew Ancliffe, Keteryne Rodrigues da Silva, Li Jiang, Johannes Gojo, Yulu Cherry Liu, Brooke Carline, Mani Kuchibhotla, Fabiano Pinto Saggioro, Suely Kazue Nagahashi Marie, Sueli Mieko Oba-Shinjo, José Andres Yunes, Rosane Gomes de Paula Queiroz, Carlos Alberto Scrideli, Raelene Endersby, Mariella G Filbin, Kleiton Silva Borges, Adrian Salic, Luiz Gonzaga Tone, Elvis Terci Valera
Publikováno v:
Neuro Oncol
Background Supratentorial RELA fusion (ST-RELA) ependymomas (EPNs) are resistant tumors without an approved chemotherapeutic treatment. Unfortunately, the molecular mechanisms that lead to chemoresistance traits of ST-RELA remain elusive. The aim of
Autor:
Ana Carolina Bueno, Mônica F Stecchini, Junier Marrero-Gutiérrez, Candy Bellido More, Leticia Ferro Leal, Débora Cristiane Gomes, Daniel Ferreira de Lima Neto, Silvia Regina Brandalise, Izilda Aparecida Cardinalli, José Andres Yunes, Thais Junqueira, Carlos Alberto Scrideli, Carlos Augusto Fernandes Molina, Fernando Silva Ramalho, Silvio Tucci, Fernanda Borchers Coeli-Lacchini, Ayrton Custodio Moreira, Leandra Ramalho, Ricardo Zorzetto Nicoliello Vêncio, Margaret De Castro, Sonir Roberto R Antonini
Publikováno v:
European Journal of Endocrinology. 186:573-585
Objective Pediatric adrenocortical tumors (pACT) display complex genomic backgrounds, lacking robust prognostic markers and targeted therapeutic options. Vitamin D3 receptor (VDR) promoter hypermethylation and underexpression were reported in adrenoc
Autor:
Ana Carolina, Bueno, Rui M P, da Silva, Mônica F, Stecchini, Junier, Marrero-Gutiérrez, Danillo C, de Almeida E Silva, Izilda, Cardinalli, Carlos Alberto, Scrideli, Thais, Junqueira, Carlos A F, Molina, Fernando Silva, Ramalho, Silvio, Tucci, Fernanda Borchers, Coeli-Lacchini, Ayrton Custodio, Moreira, Leandra N Z, Ramalho, Silvia, Brandalise, José Andres, Yunes, Margaret, de Castro, Ricardo Zorzetto Nicoliello, Vêncio, Sonir R R, Antonini
Publikováno v:
Endocrine-Related Cancer.
Children diagnosed with adrenocortical tumors (pACT) have variable outcomes and, to date, the disease lacks robust prognostic biomarkers. The prognostic potential of tumor methylation has been demonstrated in several cancers. We aimed to evaluate the
Autor:
Pablo Shimaoka Chagas, Luciana Chain Veronez, Graziella Ribeiro de Sousa, Gustavo Alencastro Veiga Cruzeiro, Carolina Alves Pereira Corrêa, Fabiano Pinto Saggioro, Rosane Gomes de Paula Queiroz, Suely Kazue Nagahashi Marie, Silvia Regina Brandalise, Izilda Aparecida Cardinalli, José Andres Yunes, Carlos Gilberto Carlotti Júnior, Hélio Rubens Machado, Marcelo Volpon Santos, Carlos Alberto Scrideli, Luiz Gonzaga Tone, Elvis Terci Valera
Groups (Grp) 3 and 4 are aggressive molecular subgroups of medulloblastoma (MB), with high rates of leptomeningeal dissemination. To date, there is still a paucity of biomarkers for these subtypes of MBs. The RNA-binding protein Musashi-1 (MSI1) is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1048243a19a6ef07a17d0705eb3c1405
https://doi.org/10.21203/rs.3.rs-1800310/v1
https://doi.org/10.21203/rs.3.rs-1800310/v1
Autor:
Bruna Coelho de Andrade, Gaby Renard, Adriano Gennari, Leonardo Luís Artico, José Ricardo Teixeira Júnior, Daniel Kuhn, Priscila Pini Zenatti Salles, Claucia Fernada Volken de Souza, Gustavo Roth, Jocelei Maria Chies, José Andrés Yunes, Luiz Augusto Basso
Publikováno v:
ACS Omega, Vol 9, Iss 32, Pp 34951-34963 (2024)
Externí odkaz:
https://doaj.org/article/5fce0fd996774cbeaeb3d880bce646a4
Autor:
Daniel Antunes Moreno, Howard Lopes Ribeiro Junior, Angelo Brunelli Albertoni Laranjeira, Gustavo Alencastro Veiga Cruzeiro, Kleiton Silva Borges, Karina Bezerra Salomão, Fernando Silva Ramalho, José Andres Yunes, Cleide Lúcia Araújo Silva, Eduardo Magalhães Rego, Carlos Alberto Scrideli, Luiz Gonzaga Tone
Patients diagnosed with acute lymphoblastic leukemia (ALL) bearing t(4;11)/MLL-AF4 have aggressive clinical features, poor prognosis and there’s an urgent need for new therapies to improve outcomes. Panobinostat (LBH589) has been identified as a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7eead5c4f8e0f6ca7f120150d783221
https://doi.org/10.21203/rs.3.rs-1594461/v1
https://doi.org/10.21203/rs.3.rs-1594461/v1
Autor:
Daniel Antunes Moreno, Howard Lopes Ribeiro Junior, Angelo Brunelli Albertoni Laranjeira, Gustavo Alencastro Veiga Cruzeiro, Kleiton Silva Borges, Karina Bezerra Salomão, Fernando Silva Ramalho, José Andres Yunes, Cleide Lúcia Araújo Silva, Eduardo Magalhães Rego, Carlos Alberto Scrideli, Luiz Gonzaga Tone
Publikováno v:
Medical oncology (Northwood, London, England). 39(12)
Patients diagnosed with acute lymphoblastic leukemia (ALL) bearing t(4;11)/MLL-AF4 have aggressive clinical features, poor prognosis and there is an urgent need for new therapies to improve outcomes. Panobinostat (LBH589) has been identified as a pot
Autor:
Keteryne Rodrigues da Silva, Luciana Chain Veronez, Carolina Alves Pereira Correa, Régia Caroline Peixoto Lira, Mirella Baroni, Rosane de Paula Silva Queiroz, Sonir Roberto Rauber Antonini, José Andres Yunes, Silvia Regina Brandalise, Luiz Gonzaga Tone, Carlos Alberto Scrideli
Publikováno v:
Human cell. 35(6)
Pediatric adrenocortical tumor (ACT) is a rare and aggressive neoplasm, with incidence in southern and southeastern Brazil 10-15 times higher than worldwide. Although microRNAs (miRNAs) have been reported to act as tumor suppressors or oncogenes in s
Autor:
Luciana Chain Veronez, Paola Fernanda Fedatto, Carolina Alves Pereira Correa, Régia Caroline Peixoto Lira, Mirella Baroni, Keteryne Rodrigues da Silva, Paula Santos, David Santos Marco Antonio, Rosane de Paula Silva Queiroz, Sonir Roberto Rauber Antonini, Silvio Tucci Jr, Luciano Neder, José Andres Yunes, Silvia Regina Brandalise, Rodrigo Alexandre Panepucci, Luiz Gonzaga Tone, Carlos Alberto Scrideli
Pediatric adrenocortical tumors (ACT) are rare aggressive neoplasms with heterogeneous prognosis. Despite extensive efforts, identifying reliable prognostic factors for pediatric patients with ACT remains a challenge. MicroRNA (miRNA) signatures have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf4686e0a8cc74ee411f4f0c49c10ac
https://doi.org/10.22541/au.163439710.04767499/v1
https://doi.org/10.22541/au.163439710.04767499/v1